Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cinemark Holdings Inc CNK

Cinemark Holdings, Inc. is a movie theatre company. The Company is engaged in the motion picture exhibition industry, with theaters in the United States, Brazil, Argentina, Chile, Colombia, Peru, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, and Paraguay. Its segments include U.S. markets and international markets. Its circuit, comprised of various brands that also include Century, Tinseltown and Rave, operates approximately 497 theaters with 5,653 screens in 42 states domestically and 13 countries throughout South and Central America. It plays mainstream films from many different genres, such as animated films, family films, dramas, comedies, horror and action films. It offers content in both 2-D and 3-D formats in all of its theaters, and in many locations, it offers either its own premium large format, XD, IMAX or ScreenX. It offers a variety of alternative entertainment content for its guests, such as concert, sporting and gaming events, and others.


NYSE:CNK - Post by User

User Avatar Image
(0)
•••
  • Denver67X
Post by Denver67on Apr 16, 2022 3:40am
270 Views
Post# 34607267

FSD Pharma Inc: Lucid MS Video

FSD Pharma Inc: Lucid MS Video


FSD Pharma is delighted to announce pre-clinical findings indicating the efficacy of Lucid-MS, its flagship medication candidate, in treating Multiple Sclerosis. Lucid-MS's therapeutic potential is an industry first, and we'd like to provide visual evidence of functional recovery in pre-clinical individuals in this video!

<< Previous
Bullboard Posts
Next >>